Effects of candesartan on electrical remodeling in the hearts of inherited dilated cardiomyopathy model mice

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Odagiri, Fuminori ^a   Inoue, Hana ^b   Sugihara, Masami ^a   Suzuki, Takeshi ^a   Murayama, Takashi ^a   Shioya, Takao ^c   Konishi, Masato ^b   Nakazato, Yuji ^a   Daida, Hiroyuki ^a   Sakurai, Takashi ^a   Morimoto, Sachio ^d   Kurebayashi, Nagomi ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

^c SAGA UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; CANDESARTAN; CANDESARTAN HEXETIL; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; POTASSIUM; POTASSIUM CHANNEL; TETRAZOLE DERIVATIVE;

ACTION POTENTIAL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHROMATIN IMMUNOPRECIPITATION; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; DRUG ACTIVITY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; HEART DILATATION; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE REMODELING; HETEROZYGOSITY; HOMOZYGOSITY; LEFT VENTRICULAR DIASTOLIC DYSFUNCTION; LIFESPAN; MOUSE; NONHUMAN; PHYSICAL ACTIVITY; PROTEIN EXPRESSION; QRS COMPLEX; QT INTERVAL; RADIOIMMUNOASSAY; ANIMAL; C57BL MOUSE; CARDIOMYOPATHY, DILATED; DISEASE MODEL; DRUG EFFECTS; ELECTROPHYSIOLOGY; GENE EXPRESSION REGULATION; GENE TARGETING; GENETICS; HEART; HEART ATRIUM REMODELING; HEART MUSCLE CELL; HEART VENTRICLE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SURVIVAL;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; ATRIAL REMODELING; BENZIMIDAZOLES; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGICAL PROCESSES; GENE EXPRESSION REGULATION; GENE KNOCK-IN TECHNIQUES; HEART; HEART VENTRICLES; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; POTASSIUM; POTASSIUM CHANNELS; SURVIVAL ANALYSIS; TETRAZOLES;

EID: 84904358561     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101838     Document Type: Article

References (31)

1. Dec GW, Fuster V (1994) Idiopathic dilated cardiomyopathy. N Engl J Med 331: 1564-1575. (Pubitemid 24366905)
2. Kasper EK, Agema WR, Hutchins GM, Deckers JW, Hare JM, et al. (1994) The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 23: 586-590. (Pubitemid 24074933)
3. Arozal W, Watanabe K, Veeraveedu PT, Thandavarayan RA, Harima M, et al. (2010) Beneficial effects of angiotensin II receptor blocker, olmesartan, in limiting the cardiotoxic effect of daunorubicin in rats. Free Radic Res 44: 1369-1377.
4. Yu H, McKinnon D, Dixon JE, Gao J, Wymore R, et al. (1999) Transient outward current, Ito1, is altered in cardiac memory. Circulation 99: 1898-1905. (Pubitemid 29181421)
5. Thuringer D, Deroubaix E, Coulombe A, Coraboeuf E, Mercadier JJ (1996) Ionic basis of the action potential prolongation in ventricular myocytes from Syrian hamsters with dilated cardiomyopathy. Cardiovasc Res 31: 747-757. (Pubitemid 26175141)
6. Pourdjabbar A, Parker TG, Nguyen QT, Desjardins JF, Lapointe N, et al. (2005) Effects of pre-, peri-, and postmyocardial infarction treatment with losartan in rats: effect of dose on survival, ventricular arrhythmias, function, and remodeling. Am J Physiol Heart Circ Physiol 288: H1997-2005. (Pubitemid 40418031)
7. Cohn JN, Tognoni G (2001) A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 345: 1667-1675. (Pubitemid 33126822)
8. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, et al. (2003) Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet 362: 759-766. (Pubitemid 37093915)
9. Nieminen T, Verrier RL (2010) Usefulness of T-wave alternans in sudden death risk stratification and guiding medical therapy. Ann Noninvasive Electrocardiol 15: 276-288.
10. Otten E, Lekanne Dit Deprez RH, Weiss MM, van Slegtenhorst M, Joosten M, et al. (2010) Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathy. Neth Heart J 18: 478-485.
11. Morimoto S (2009) Expanded spectrum of gene causing both hypertrophic cardiomyopathy and dilated cardiomyopathy. Circ Res 105: 313-315.
12. Du CK, Morimoto S, Nishii K, Minakami R, Ohta M, et al. (2007) Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res 101: 185-194. (Pubitemid 47196586)
13. Suzuki T, Shioya T, Murayama T, Sugihara M, Odagiri F, et al. (2012) Multistep ion channel remodeling and lethal arrhythmia precede heart failure in a mouse model of inherited dilated cardiomyopathy. PLoS One 7: e35353.
14. Wang YY, Morimoto S, Du CK, Lu QW, Zhan DY, et al. (2010) Up-regulation of type 2 iodothyronine deiodinase in dilated cardiomyopathy. Cardiovasc Res 87: 636-646.
15. Mitchell GF, Jeron A, Koren G (1998) Measurement of heart rate and Q-T interval in the conscious mouse. Am J Physiol 274: H747-751.
16. Sugihara M, Odagiri F, Suzuki T, Murayama T, Nakazato Y, et al. (2013) Usefulness of running wheel for detection of congestive heart failure in dilated cardiomyopathy mouse model. PLoS One 8: e55514.
17. Nishizawa H, Suzuki T, Shioya T, Nakazato Y, Daida H, et al. (2009) Causes of abnormal Ca2+ transients in Guinea pig pathophysiological ventricular muscle revealed by Ca2+ and action potential imaging at cellular level. PLoS One 4: e7069.
18. Shioya T (2007) A simple technique for isolating healthy heart cells from mouse models. J Physiol Sci 57: 327-335.
19. Brouillette J, Clark RB, Giles WR, Fiset C (2004) Functional properties of K+ currents in adult mouse ventricular myocytes. J Physiol 559: 777-798. (Pubitemid 39276168)
20. Goldberg MR, Bradstreet TE, McWilliams EJ, Tanaka WK, Lipert S, et al. (1995) Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients. Hypertension 25: 37-46.
21. Inada Y, Wada T, Ojima M, Sanada T, Shibouta Y, et al. (1997) Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 19: 1079-1099. (Pubitemid 27431498)
22. Hongo K, Morimoto S, O-Uchi J, Kusakari Y, Komukai K, et al. RENNINANGIOTENSIN SYSTEM PLAYS AN IMPORTANT ROLE IN THE PATHOGENESIS OF DCM IN MOUSE; 2009; Kyoto, Japan. Springer. pp. 24.
23. Qin M, Huang H, Wang T, Hu H, Liu Y, et al. (2012) Absence of Rgs5 prolongs cardiac repolarization and predisposes to ventricular tachyarrhythmia in mice. J Mol Cell Cardiol 53: 880-890.
24. Nattel S, Maguy A, Le Bouter S, Yeh YH (2007) Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation. Physiol Rev 87: 425-456. (Pubitemid 47084677)
25. Janse MJ (2004) Electrophysiological changes in heart failure and their relationship to arrhythmogenesis. Cardiovasc Res 61: 208-217.
26. Rosati B, McKinnon D (2004) Regulation of ion channel expression. Circ Res 94: 874-883. (Pubitemid 38490064)
27. Shimoni Y, Liu XF (2003) Role of PKC in autocrine regulation of rat ventricular K+ currents by angiotensin and endothelin. Am J Physiol Heart Circ Physiol 284: H1168-1181. (Pubitemid 36348579)
28. Bru-Mercier G, Deroubaix E, Capuano V, Ruchon Y, Rucker-Martin C, et al. (2003) Expression of heart K+ channels in adrenalectomized and catecholaminedepleted reserpine-treated rats. J Mol Cell Cardiol 35: 153-163. (Pubitemid 36269190)
29. Takimoto K, Levitan ES (1994) Glucocorticoid induction of Kv1.5 K+ channel gene expression in ventricle of rat heart. Circ Res 75: 1006-1013. (Pubitemid 24351446)
30. Yue L, Xie J, Nattel S (2011) Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc Res 89: 744-753.
31. Rivard K, Paradis P, Nemer M, Fiset C (2008) Cardiac-specific overexpression of the human type 1 angiotensin II receptor causes delayed repolarization. Cardiovasc Res 78: 53-62. (Pubitemid 351430969)